Amphastar Pharmaceuticals, Inc. (AMPH)
25.94
-0.20
(-0.77%)
USD |
NASDAQ |
Oct 20, 16:00
25.58
-0.36
(-1.39%)
After-Hours: 20:00
Amphastar Pharmaceuticals Gross Profit (TTM) : 332.97M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 332.97M |
| March 31, 2026 | 325.87M |
| December 31, 2025 | 341.45M |
| September 30, 2025 | 342.97M |
| June 30, 2025 | 346.61M |
| March 31, 2025 | 356.16M |
| December 31, 2024 | 361.37M |
| September 30, 2024 | 371.57M |
| June 30, 2024 | 378.86M |
| March 31, 2024 | 359.86M |
| December 31, 2023 | 343.96M |
| September 30, 2023 | 319.03M |
| June 30, 2023 | 269.11M |
| March 31, 2023 | 256.87M |
| December 31, 2022 | 238.67M |
| September 30, 2022 | 223.59M |
| June 30, 2022 | 216.19M |
| March 31, 2022 | 199.81M |
| December 31, 2021 | 188.62M |
| September 30, 2021 | 169.22M |
| June 30, 2021 | 154.50M |
| March 31, 2021 | 140.79M |
| December 31, 2020 | 133.26M |
| September 30, 2020 | 130.34M |
| June 30, 2020 | 129.51M |
| Date | Value |
|---|---|
| March 31, 2020 | 129.03M |
| December 31, 2019 | 123.33M |
| September 30, 2019 | 125.51M |
| June 30, 2019 | 120.39M |
| March 31, 2019 | 114.59M |
| December 31, 2018 | 101.25M |
| September 30, 2018 | 86.52M |
| June 30, 2018 | 78.10M |
| March 31, 2018 | 79.31M |
| December 31, 2017 | 85.62M |
| September 30, 2017 | 85.73M |
| June 30, 2017 | 92.62M |
| March 31, 2017 | 97.52M |
| December 31, 2016 | 99.45M |
| September 30, 2016 | 112.93M |
| June 30, 2016 | 103.17M |
| March 31, 2016 | 84.97M |
| December 31, 2015 | 73.55M |
| September 30, 2015 | 53.24M |
| June 30, 2015 | 48.35M |
| March 31, 2015 | 51.02M |
| December 31, 2014 | 50.46M |
| September 30, 2014 | 57.27M |
| June 30, 2014 | 65.76M |
| March 31, 2014 | 78.25M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Viatris, Inc. | 5.838B |
| Johnson & Johnson | 68.45B |
| Eli Lilly & Co. | 66.44B |
| Merck & Co., Inc. | 48.01B |
| Pfizer Inc. | 41.30B |